 | |||||||
| lose weight | |||||||
| NEWS | |||||||
| Is yo-yo dieting bad for you? Here's what the latest research shows - The Conversation Weight loss is beneficial for your health – even if it requires a few attempts to get to your goal weight.
| |||||||
| The Weight Loss Medication Revolution: Uncovering Answers about GLP-1s and Cancer Dr. Kristin Altwegg, recipient of the AICR/WCRF Marilyn Gentry Fellowship, is researching whether GLP-1 weight loss drugs influence obesity-related ...
| |||||||
| NHS England to offer weight-loss drugs to 1.2m people to reduce risk of heart attacks and strokes People who are not obese but overweight and at risk of serious cardiovascular events eligible for weekly jabs.
| |||||||
| Fitness app helps people lose weight 'without changing your lifestyle' - Her.ie The Simple Life app is a weight loss tool that helps you drop the pounds without restrictive dieting, including calorie counting.
| |||||||
| Aussie mums are losing up to 10kg in just eight weeks after simple lifestyle tweak ... lose weight, but develop healthy habits to continue to keep excess weight off. equ founder Amal Wakim went from a size 14 to a six, losing 30kg after.
| |||||||
| NHS to give fat jabs to 1.2m patients to stop heart attacks - The Telegraph Health service to roll out semaglutide as trials suggest it can reduce risk of major heart events by a fifth.
| |||||||
| Over 1 million to be offered weight loss drug on NHS to prevent heart attack or stroke - BHF The weight loss jab Wegovy will soon be prescribed on the NHS to over 1 million people with cardiovascular disease to help prevent them from ...
| |||||||
Wegovy price drops: New subscription program promises big savings - YouTube The maker of the weight-loss drug Wegovy is promising a lower monthly price for patients who enroll in a new subscription program.
| |||||||
| A step forward for type 1 beta cell therapy and drug shows promise to treat type 2 This could lead to bigger improvements in blood sugar control and support weight loss in a more powerful way than current incretin treatments. In ...
| |||||||
| See more results | Edit this alert | |||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
